Veritable’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-31,128
| Closed | -$3.09M | – | 847 |
|
|
2019
Q3 | $3.09M | Buy |
31,128
+648
| +2% | +$61.6K | 0.06% | 165 |
|
|
2019
Q2 | $2.82M | Buy |
30,480
+1,432
| +5% | +$136K | 0.06% | 173 |
|
|
2019
Q1 | $2.74M | Sell |
29,048
-490
| -2% | -$42.9K | 0.06% | 174 |
|
|
2018
Q4 | $1.89M | Sell |
29,538
-867
| -3% | -$64K | 0.04% | 207 |
|
|
2018
Q3 | $2.72M | Sell |
30,405
-2,152
| -7% | -$190K | 0.05% | 175 |
|
|
2018
Q2 | $2.59M | Sell |
32,557
-326
| -1% | -$27.1K | 0.05% | 173 |
|
|
2018
Q1 | $2.93M | Buy |
32,883
+1,139
| +4% | +$109K | 0.06% | 163 |
|
|
2017
Q4 | $3.31M | Sell |
31,744
-9,192
| -22% | -$1.04M | 0.07% | 154 |
|
|
2017
Q3 | $5.97M | Sell |
40,936
-9,949
| -20% | -$1.36M | 0.13% | 111 |
|
|
2017
Q2 | $6.61M | Buy |
50,885
+4,613
| +10% | +$565K | 0.15% | 99 |
|
|
2017
Q1 | $5.76M | Buy |
46,272
+304
| +0.7% | +$36.4K | 0.14% | 104 |
|
|
2016
Q4 | $5.32M | Sell |
45,968
-14,078
| -23% | -$1.57M | 0.13% | 107 |
|
|
2016
Q3 | $6.28M | Buy |
60,046
+1,712
| +3% | +$185K | 0.16% | 91 |
|
|
2016
Q2 | $5.75M | Buy |
58,334
+295
| +0.5% | +$30.5K | 0.15% | 98 |
|
|
2016
Q1 | $5.81M | Buy |
58,039
+279
| +0.5% | +$28.7K | 0.15% | 98 |
|
|
2015
Q4 | $6.92M | Buy |
57,760
+52
| +0.1% | +$6.02K | 0.19% | 83 |
|
|
2015
Q3 | $6.24M | Buy |
57,708
+1,203
| +2% | +$149K | 0.18% | 83 |
|
|
2015
Q2 | $6.54M | Sell |
56,505
-46,465
| -45% | -$5.31M | 0.18% | 88 |
|
|
2015
Q1 | $11.9M | Buy |
102,970
+172
| +0.2% | +$20.6K | 0.25% | 64 |
|
|
2014
Q4 | $11.5M | Buy |
102,798
+58
| +0.1% | +$6.12K | 0.24% | 70 |
|
|
2014
Q3 | $9.74M | Buy |
102,740
+35,222
| +52% | +$3.18M | 0.21% | 82 |
|
|
2014
Q2 | $5.8M | Sell |
67,518
-116
| -0.2% | -$8.82K | 0.12% | 128 |
|
|
2014
Q1 | $4.72M | Sell |
67,634
-1,630
| -2% | -$129K | 0.1% | 145 |
|
|
2013
Q4 | $5.85M | Sell |
69,264
-1,856
| -3% | -$147K | 0.13% | 126 |
|
|
2013
Q3 | $5.48M | Sell |
71,120
-37,482
| -35% | -$2.63M | 0.13% | 125 |
|
|
2013
Q2 | $6.35M | Buy |
+108,602
| New | +$6.54M | 0.15% | 111 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Veritable's CELG Position: Q4 2019 in Review
Veritable sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 31,128 shares — an estimated $3.09M sold.
Veritable first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $11.9M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Veritable reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Veritable sold 31,128 Celgene Corp shares in Q4 2019, an estimated $3.09M.
- Veritable first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Veritable's Celgene Corp position peaked at $11.9M in Q1 2015.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Veritable's 13F filing for Q4 2019, filed 14 Feb 2020.